Literature DB >> 18436147

Understanding proteasome assembly and regulation: importance to cardiovascular medicine.

Glen W Young1, Yueju Wang, Peipei Ping.   

Abstract

The cardiac proteasome is increasingly recognized as a complex, heterogeneous, and dynamic organelle contributing to the modulation of cardiac function in health and diseases. The emerging picture of the proteasome system reveals a highly regulated and organized molecular machine integrated into multiple biologic processes of the cell. Full appreciation of its cardiovascular relevance requires an understanding of its proteolytic function as well as its underlying regulatory mechanisms, of which assembly, stoichiometry, posttranslational modification, and the role of the associating partners are increasingly poignant.

Mesh:

Substances:

Year:  2008        PMID: 18436147      PMCID: PMC2441911          DOI: 10.1016/j.tcm.2008.01.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  40 in total

1.  Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion.

Authors:  A L Bulteau; K C Lundberg; K M Humphries; H A Sadek; P A Szweda; B Friguet; L I Szweda
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  PI31 is a modulator of proteasome formation and antigen processing.

Authors:  Dietmar M W Zaiss; Sybille Standera; Peter-M Kloetzel; Alice J A M Sijts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

3.  A proteasome inhibitor confers cardioprotection.

Authors:  Hartmut Lüss; Wilhelm Schmitz; Joachim Neumann
Journal:  Cardiovasc Res       Date:  2002-04       Impact factor: 10.787

4.  In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes.

Authors:  Xin Dong; Jinbao Liu; Hanqiao Zheng; Joseph W Glasford; Wei Huang; Quan Hai Chen; Niels R Harden; Faqian Li; A Martin Gerdes; Xuejun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-22       Impact factor: 4.733

5.  Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.

Authors:  Joseph Pye; Farhad Ardeshirpour; Arlene McCain; Dwight A Bellinger; Elizabeth Merricks; Julian Adams; Peter J Elliott; Christine Pien; Thomas H Fischer; Albert S Baldwin; Timothy C Nichols
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11-07       Impact factor: 4.733

6.  Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection.

Authors:  Karl Stangl; Christoph Günther; Thomas Frank; Mario Lorenz; Silke Meiners; Thorsten Röpke; Lars Stelter; Minoo Moobed; Gert Baumann; Peter-Michael Kloetzel; Verena Stangl
Journal:  Biochem Biophys Res Commun       Date:  2002-03-01       Impact factor: 3.575

7.  Multiubiquitin chain receptors define a layer of substrate selectivity in the ubiquitin-proteasome system.

Authors:  Rati Verma; Robert Oania; Johannes Graumann; Raymond J Deshaies
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

8.  BAG-1 proteins protect cardiac myocytes from simulated ischemia/reperfusion-induced apoptosis via an alternate mechanism of cell survival independent of the proteasome.

Authors:  Paul A Townsend; Ramsey I Cutress; Christopher J Carroll; Kevin M Lawrence; Tiziano M Scarabelli; Graham Packham; Anastasis Stephanou; David S Latchman
Journal:  J Biol Chem       Date:  2004-02-20       Impact factor: 5.157

9.  Protein-protein interactions among human 20S proteasome subunits and proteassemblin.

Authors:  Krupakar Jayarapu; Thomas A Griffin
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

10.  Nob1p is required for biogenesis of the 26S proteasome and degraded upon its maturation in Saccharomyces cerevisiae.

Authors:  Yoshiko Tone; Akio Toh-E
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

View more
  14 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

3.  Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues.

Authors:  Aldrin V Gomes; Glen W Young; Yueju Wang; Chenggong Zong; Mansoureh Eghbali; Oliver Drews; Haojie Lu; Enrico Stefani; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2008-10-17       Impact factor: 5.911

4.  Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.

Authors:  Viswanathan Rajagopalan; Mingming Zhao; Sushma Reddy; Giovanni Fajardo; Xuejun Wang; Shannamar Dewey; Aldrin V Gomes; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-31       Impact factor: 4.733

Review 5.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 6.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 7.  The role of the proteasome in heart disease.

Authors:  Yi-Fan Li; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2010-09-15

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  Clarifying the cardiac proteasome paradox: protein quality control.

Authors:  Christopher C Glembotski
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

10.  A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome.

Authors:  Jinbao Liu; Hanqiao Zheng; Mingxin Tang; Youn-Chul Ryu; Xuejun Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.